Twin Tree Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Twin Tree Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,200	Closed	-$1.3M	–	1756
2021 Q4	$1.3M	Buy	10,200 +7,500	+278%	+$986K	﹤0.01%	1183
2021 Q3	$352K	Buy	+2,700	New	+$408K	﹤0.01%	1336
2020 Q3	–	Sell	-3,600	Closed	-$397K	–	1418
2020 Q2	$397K	Buy	+3,600	New	+$398K	﹤0.01%	1188
2019 Q3	–	Sell	-2,100	Closed	-$299K	–	1353
2019 Q2	$299K	Buy	+2,100	New	+$282K	﹤0.01%	937
2017 Q3	–	Sell	-4,700	Closed	-$731K	–	1066
2017 Q2	$731K	Buy	+4,700	New	+$719K	0.01%	701
2016 Q3	–	Sell	-5,700	Closed	-$805K	–	1239
2016 Q2	$805K	Buy	5,700 +4,500	+375%	+$663K	0.01%	713
2016 Q1	$157K	Sell	1,200 -1,400	-54%	-$174K	﹤0.01%	1049
2015 Q4	$365K	Buy	2,600 +1,900	+271%	+$263K	0.01%	952
2015 Q3	$93K	Buy	+700	New	+$121K	﹤0.01%	1117

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Twin Tree Management's JAZZ Position: Q3 2021 in Review

Twin Tree Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 16,974 shares — an estimated $2.56M sold.

Twin Tree Management first reported a position in JAZZ in Q4 2014 and held it in 19 quarters. The position peaked at $3.02M in Q2 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.

Twin Tree Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Twin Tree Management sold 16,974 Jazz Pharmaceuticals shares in Q3 2021, an estimated $2.56M.
Twin Tree Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 19 quarters.
Twin Tree Management's Jazz Pharmaceuticals position peaked at $3.02M in Q2 2021.
455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.

Based on Twin Tree Management's 13F filing for Q3 2021, filed 12 Nov 2021.